{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:13:23Z","timestamp":1793798003949,"version":"4.6.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR081487"],"award-info":[{"award-number":["AR081487"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.isci.2025.112714","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T20:54:46Z","timestamp":1748638486000},"page":"112714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The TWEAK\/Fn14 signaling mediates skeletal muscle wasting during cancer cachexia"],"prefix":"10.1016","volume":"28","author":[{"given":"Meiricris","family":"Tomaz da Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anirban","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh Tuan","family":"Vuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniket S.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristeena","family":"Josphien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana V.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajedah M.","family":"Hindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vihang A.","family":"Narkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8571-2848","authenticated-orcid":false,"given":"Ashok","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.112714_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.isci.2025.112714_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.isci.2025.112714_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41571-023-00734-5","article-title":"Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management","volume":"20","author":"Argiles","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2025.112714_bib4","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190450","article-title":"Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia","volume":"218","author":"Rupert","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2025.112714_bib5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.tips.2023.07.006","article-title":"Muscle wasting: emerging pathways and potential drug targets","volume":"44","author":"Domaniku","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.isci.2025.112714_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.devcel.2018.12.003","article-title":"Tumor-Derived Ligands Trigger Tumor Growth and Host Wasting via Differential MEK Activation","volume":"48","author":"Song","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.isci.2025.112714_bib7","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s42003-023-04902-2","article-title":"Blocking muscle wasting via deletion of the muscle-specific E3 ligase MuRF1 impedes pancreatic tumor growth","volume":"6","author":"Neyroud","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.isci.2025.112714_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41467-020-20123-1","article-title":"Mechanisms of muscle atrophy and hypertrophy: implications in health and disease","volume":"12","author":"Sartori","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112714_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1242\/dmm.010389","article-title":"Cellular and molecular mechanisms of muscle atrophy","volume":"6","author":"Bonaldo","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.isci.2025.112714_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/febs.14358","article-title":"ER stress in skeletal muscle remodeling and myopathies","volume":"286","author":"Afroze","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.isci.2025.112714_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jcp.25852","article-title":"Emerging roles of ER stress and unfolded protein response pathways in skeletal muscle health and disease","volume":"233","author":"Bohnert","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.isci.2025.112714_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrc3800","article-title":"The impact of the endoplasmic reticulum protein-folding environment on cancer development","volume":"14","author":"Wang","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2025.112714_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.cdd.4401840","article-title":"From acute ER stress to physiological roles of the Unfolded Protein Response","volume":"13","author":"Wu","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.isci.2025.112714_bib14","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1096\/fj.201600250RR","article-title":"Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia","volume":"30","author":"Bohnert","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2025.112714_bib15","doi-asserted-by":"crossref","first-page":"e00184-19","DOI":"10.1128\/MCB.00184-19","article-title":"The Toll-Like Receptor\/MyD88\/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting during Cancer Cachexia","volume":"39","author":"Bohnert","year":"2019","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.isci.2025.112714_bib16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.smim.2014.02.006","article-title":"TWEAK\/Fn14 axis: the current paradigm of tissue injury-inducible function in the midst of complexities","volume":"26","author":"Burkly","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.isci.2025.112714_bib17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1189\/jlb.0308165","article-title":"No end in site: TWEAK\/Fn14 activation and autoimmunity associated- end-organ pathologies","volume":"84","author":"Zheng","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.isci.2025.112714_bib18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrd2488","article-title":"The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting","volume":"7","author":"Winkles","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2025.112714_bib19","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/jid.2012.402","article-title":"The TWEAK receptor Fn14 is a therapeutic target in melanoma: immunotoxins targeting Fn14 receptor for malignant melanoma treatment","volume":"133","author":"Zhou","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.isci.2025.112714_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ajpath.2012.03.026","article-title":"Elevated expression of Fn14 in non-small cell lung cancer correlates with activated EGFR and promotes tumor cell migration and invasion","volume":"181","author":"Whitsett","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.isci.2025.112714_bib21","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1158\/1535-7163.MCT-14-0346","article-title":"Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC","volume":"13","author":"Zhou","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.isci.2025.112714_bib22","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1158\/0008-5472.CAN-06-0418","article-title":"Increased fibroblast growth factor-inducible 14 expression levels promote glioma cell invasion via Rac1 and nuclear factor-kappaB and correlate with poor patient outcome","volume":"66","author":"Tran","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2025.112714_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317714624","article-title":"TWEAK\/Fn14 signaling in tumors","volume":"39","author":"Hu","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.isci.2025.112714_bib24","first-page":"859","article-title":"Clinical correlations and prognostic relevance of Fn14 expression in breast carcinoma","volume":"28","author":"Wang","year":"2013","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.isci.2025.112714_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cytogfr.2013.12.004","article-title":"The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease","volume":"25","author":"Tajrishi","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.isci.2025.112714_bib26","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1096\/fj.06-7537com","article-title":"TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine","volume":"21","author":"Dogra","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2025.112714_bib27","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1096\/fj.14-260703","article-title":"Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction","volume":"29","author":"Sato","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2025.112714_bib28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1083\/jcb.200909117","article-title":"The TWEAK\u2013Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice","volume":"188","author":"Mittal","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.isci.2025.112714_bib29","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1128\/MCB.06351-11","article-title":"The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms","volume":"32","author":"Paul","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.isci.2025.112714_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2014.00018","article-title":"TWEAK\/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction","volume":"5","author":"Sato","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.112714_bib31","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1152\/ajpendo.00240.2015","article-title":"Heightened TWEAK-NF-kappaB signaling and inflammation-associated fibrosis in paralyzed muscles of men with chronic spinal cord injury","volume":"310","author":"Yarar-Fisher","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2025.112714_bib32","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201583R","article-title":"Targeted ablation of Fn14 receptor improves exercise capacity and inhibits neurogenic muscle atrophy","volume":"36","author":"Tomaz da Silva","year":"2022","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2025.112714_bib33","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.cell.2015.08.031","article-title":"Targeting of Fn14 Prevents Cancer-Induced Cachexia and Prolongs Survival","volume":"162","author":"Johnston","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.112714_bib34","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/jcsm.12225","article-title":"Establishment and characterization of a novel murine model of pancreatic cancer cachexia","volume":"8","author":"Michaelis","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.isci.2025.112714_bib35","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physiolgenomics.00061.2018","article-title":"Transcriptomic analysis of the development of skeletal muscle atrophy in cancer-cachexia in tumor-bearing mice","volume":"50","author":"Blackwell","year":"2018","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.isci.2025.112714_bib36","article-title":"A comprehensive review of animal models for cancer cachexia: Implications for translational research","volume":"11","author":"Li","year":"2024","journal-title":"Genes Dis."},{"key":"10.1016\/j.isci.2025.112714_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136687","article-title":"Formation of colorectal liver metastases induces musculoskeletal and metabolic abnormalities consistent with exacerbated cachexia","volume":"5","author":"Huot","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.isci.2025.112714_bib38","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/jcp.22821","article-title":"TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases","volume":"227","author":"Bhatnagar","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.isci.2025.112714_bib39","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1083\/jcb.200909117","article-title":"The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice","volume":"188","author":"Mittal","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.isci.2025.112714_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2025.112714_bib41","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1021\/jm300713s","article-title":"Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-p yrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)","volume":"55","author":"Axten","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.isci.2025.112714_bib42","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1021\/ml400228e","article-title":"Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development","volume":"4","author":"Axten","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.isci.2025.112714_bib43","article-title":"Oncostatin M signaling drives cancer-associated skeletal muscle wasting","volume":"5","author":"Domaniku-Waraich","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.112714_bib44","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1172\/JCI116897","article-title":"Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model","volume":"92","author":"Costelli","year":"1993","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2025.112714_bib45","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1007\/s00259-024-06836-1","article-title":"Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice","volume":"51","author":"Burvenich","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.isci.2025.112714_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/genes14091818","article-title":"Alpha-Ketoglutarate Regulates Tnfrsf12a\/Fn14 Expression via Histone Modification and Prevents Cancer-Induced Cachexia","volume":"14","author":"Ruiz","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.isci.2025.112714_bib47","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2024.03.009","article-title":"The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2025.112714_bib48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2025.112714_bib49","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1016\/j.jmb.2019.05.032","article-title":"Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function","volume":"431","author":"Penna","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.isci.2025.112714_bib50","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ajpath.2012.12.023","article-title":"Autophagic degradation contributes to muscle wasting in cancer cachexia","volume":"182","author":"Penna","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.isci.2025.112714_bib51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","article-title":"Cancer cachexia: molecular mechanisms and treatment strategies","volume":"16","author":"Setiawan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.isci.2025.112714_bib52","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1038\/s41598-017-02088-2","article-title":"Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling","volume":"7","author":"Pettersen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.112714_bib53","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.1993.126","article-title":"Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia","volume":"67","author":"Smith","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.isci.2025.112714_bib54","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jcsm.13073","article-title":"Molecular mechanisms of cancer cachexia-related loss of skeletal muscle mass: data analysis from preclinical and clinical studies","volume":"14","author":"Martin","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.isci.2025.112714_bib55","doi-asserted-by":"crossref","first-page":"C66","DOI":"10.1152\/ajpcell.00052.2015","article-title":"Lewis lung carcinoma regulation of mechanical stretch-induced protein synthesis in cultured myotubes","volume":"310","author":"Gao","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.isci.2025.112714_bib56","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1038\/s41467-024-50071-z","article-title":"TWEAK\/Fn14 signalling driven super-enhancer reprogramming promotes pro-metastatic metabolic rewiring in triple-negative breast cancer","volume":"15","author":"Sim","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.112714_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2011.01054.x","article-title":"TWEAK\/Fn14 pathway: an immunological switch for shaping tissue responses","volume":"244","author":"Burkly","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.isci.2025.112714_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052567","article-title":"Confounding Roles of ER Stress and the Unfolded Protein Response in Skeletal Muscle Atrophy","volume":"22","author":"Gallot","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.112714_bib59","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1096\/fj.201800683RR","article-title":"PERK regulates skeletal muscle mass and contractile function in adult mice","volume":"33","author":"Gallot","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2025.112714_bib60","article-title":"ER stress and ERO1: Potential therapeutic targets for inherited myopathies","volume":"5","author":"Roy","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.112714_bib61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tibs.2015.01.002","article-title":"UPR, autophagy, and mitochondria crosstalk underlies the ER stress response","volume":"40","author":"Senft","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.isci.2025.112714_bib62","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1080\/15548627.2020.1788889","article-title":"The unfolded protein response regulates hepatic autophagy by sXBP1-mediated activation of TFEB","volume":"17","author":"Zhang","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.isci.2025.112714_bib63","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41392-023-01570-w","article-title":"Endoplasmic reticulum stress: molecular mechanism and therapeutic targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.isci.2025.112714_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi8823","article-title":"TWEAK functions with TNF and IL-17 on keratinocytes and is a potential target for psoriasis therapy","volume":"6","author":"Gupta","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.isci.2025.112714_bib65","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2248","article-title":"Isolation, Culturing, and Differentiation of Primary Myoblasts from Skeletal Muscle of Adult Mice","volume":"7","author":"Hindi","year":"2017","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.isci.2025.112714_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1049640","article-title":"Screening of GPCR drugs for repurposing in breast cancer","volume":"13","author":"Abdulkareem","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2025.112714_bib67","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98441","article-title":"TAK1 regulates skeletal muscle mass and mitochondrial function","volume":"3","author":"Hindi","year":"2018","journal-title":"JCI Insight"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225009757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225009757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:52:13Z","timestamp":1777945933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225009757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2589004225009757"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.112714","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.06.616866","asserted-by":"object"}]},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The TWEAK\/Fn14 signaling mediates skeletal muscle wasting during cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.112714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112714"}}